Filing Details

Accession Number:
0001567619-18-003780
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-10-05 18:01:57
Reporting Period:
2018-10-03
Accepted Time:
2018-10-05 18:01:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1557533 Robert Jeffrey Ajer C/O Biomarin Pharmaceutical Inc.,
105 Digital Drive
Novato CA 94949
Evp, Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-10-03 1,000 $98.98 49,135 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Trade made pursuant to a 10b5-1 plan executed on September 10, 2018.
  2. The price in column 4 is the weighted average price. The price actually received ranged from $98.76 to $99.18. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.